Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115745836B reveals novel photoredox route for alkyl radicals. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN112708902B reveals a metal-free electrochemical route for indoles. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable green chemistry.
Novel Z-M compounds optimize Enzalutamide production reducing toxicity and enhancing supply chain reliability for global pharmaceutical intermediates manufacturing partners seeking efficiency.
Novel patent CN104829588A offers high-yield benzo[b]thiophene intermediate synthesis. Reduces costs and improves supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN111018901A reveals a novel synthetic route for Zanamivir and Laninamivir intermediates, offering enhanced purity and cost-effective manufacturing solutions.
Novel chiral phosphoric acid catalyzed method offers high yield and mild conditions for pharmaceutical intermediate manufacturing supply chain optimization and reliability.
Novel synthesis method improves yield and purity for cardiovascular intermediates. Offers cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN114478361B reveals a metal-free coupling method for nitrogen heteroaromatics, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel 6-step synthesis of Tenuifoliside B from sucrose. High yield, mild conditions, scalable process for neuroprotective drug development.
Patent CN1900073A discloses a novel acid-catalyzed condensation for N-phenyl-2-pyrimidyl amines, offering a cost-effective and scalable route for pharmaceutical intermediates.
Novel one-pot synthesis for Teneligliptin intermediate offers high purity and cost efficiency for pharmaceutical manufacturing supply chains globally.
Novel process for 1,3-benzodioxole compounds eliminates chromatography, boosts yield, and ensures supply chain reliability for pharmaceutical intermediates.
Patent CN100425598C details a novel one-step synthesis of chiral oxazolines using Lewis acid catalysts, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN116217654A reveals a stable intermediate route for LE14 ADC payloads, offering cost reduction in ADC manufacturing and reliable supply chain solutions.
Novel palladium-catalyzed carbonylation patent offers cost-effective high-purity pharmaceutical intermediates with scalable supply chain reliability for global procurement teams.
Novel patent method ensures >99.5% purity vortioxetine hydrobromide. Reduced costs and scalable supply chain for global pharmaceutical procurement teams.
Patent CN102060731B reveals a cost-effective 3-step route for 2-acetamido-6-acetylphenol, offering significant supply chain advantages for Pranlukast manufacturing.
Patent CN103420908A reveals a high-yield asymmetric hydrogenation route for Montelukast intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN105408302B reveals advanced purification method. Enhances supply chain reliability and drives cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN120794897A details a novel salifying extraction method for Evocalcet. This process ensures high purity and cost reduction in API manufacturing for global supply chains.